Clinical Trials Browser

Uterine Cervical Neoplasms × Albumin-Bound Paclitaxel × Clear all

NCT06511726 2026-06-04

CATPCC-01

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms, Recurrence

NCT05367206 2022-05-10

N6C

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05290935 2022-03-22

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04188860 2022-03-15

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Phase 2 Completed

Uterine Cervical Neoplasms

NCT02476955 2020-09-30

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Phase 1 Terminated

BreastGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT00309959 2019-01-08

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Phase 2 Completed

37 enrolled 7 charts

Uterine Cervical Neoplasms

NCT01667211 2012-08-22

CSAPPPCC

Phase 2 Unknown

Uterine Cervical Neoplasms